Article
Milk glycan metabolism by intestinal bifidobacteria: insights from comparative genomics
2 Nov 2022
Abstract excerpt
Bifidobacteria are early colonizers of the human neonatal gut and provide multiple health benefits to the infant, including inhibiting the growth of enteropathogens and modulating the immune system. Certain Bifidobacterium species prevail in the gut of breastfed infants due to the ability of these microorganisms to selectively forage glycans present in human milk, specifically human milk oligosaccharides (HMOs)...
Topics
Join the communities discussing this publication.